We have located links that may give you full text access.
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: The ESC-EORP CICD-LT registry.
European Journal of Preventive Cardiology 2022 June 3
BACKGROUND: In Europe, global data on guideline adherence, geographic variations and determinants of clinical events in Chronic coronary syndrome (CCS) patients remain suboptimal.
DESIGN: The European Society of Cardiology (ESC) EORP CICD-LT registry is a prospective European registry, was designed to describe the profile, management and outcomes of patients with CCS across the ESC countries.
METHODS: We aimed to investigate clinical events at one-year follow-up from the ESC EORP CICD-LT Registry.
RESULTS: One-year outcomes of 6655 patients from the 9174 recruited in this European registry were analyzed. Overall, 168 patients (2.5%) died, mostly from CV causes (n= 97, 1.5%). Northern Europe had the lowest CV mortality rate, while southern Europe had the highest (0.5% vs 2.0%, p= 0.04). Women had a higher rate of CV mortality compared with men (2.0% vs 1.3%, p = 0.02). During follow-up, 1606 patients (27.1%) were hospitalized at least once, predominantly for CV indications (n = 1220, 20.6%). Among the population with measured LDL-cholesterol level at one-year, 1434 patients (66.5%) were above the recommended target. Age, history of atrial fibrillation, previous stroke, liver disease, chronic obstructive pulmonary disease or asthma, increased serum creatinine and impaired left ventricular function were associated with an increased risk of CV death or hospitalization.
CONCLUSION: In the CICD registry, the majority of patients with CCS have uncontrolled CV risk factors. The one year mortality rate is low, but these patients are frequently hospitalized for CV causes. Early identification of comorbidities may represent an opportunity for enhanced care and better outcomes.
DESIGN: The European Society of Cardiology (ESC) EORP CICD-LT registry is a prospective European registry, was designed to describe the profile, management and outcomes of patients with CCS across the ESC countries.
METHODS: We aimed to investigate clinical events at one-year follow-up from the ESC EORP CICD-LT Registry.
RESULTS: One-year outcomes of 6655 patients from the 9174 recruited in this European registry were analyzed. Overall, 168 patients (2.5%) died, mostly from CV causes (n= 97, 1.5%). Northern Europe had the lowest CV mortality rate, while southern Europe had the highest (0.5% vs 2.0%, p= 0.04). Women had a higher rate of CV mortality compared with men (2.0% vs 1.3%, p = 0.02). During follow-up, 1606 patients (27.1%) were hospitalized at least once, predominantly for CV indications (n = 1220, 20.6%). Among the population with measured LDL-cholesterol level at one-year, 1434 patients (66.5%) were above the recommended target. Age, history of atrial fibrillation, previous stroke, liver disease, chronic obstructive pulmonary disease or asthma, increased serum creatinine and impaired left ventricular function were associated with an increased risk of CV death or hospitalization.
CONCLUSION: In the CICD registry, the majority of patients with CCS have uncontrolled CV risk factors. The one year mortality rate is low, but these patients are frequently hospitalized for CV causes. Early identification of comorbidities may represent an opportunity for enhanced care and better outcomes.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app